JP2025505142A5 - - Google Patents

Info

Publication number
JP2025505142A5
JP2025505142A5 JP2024545809A JP2024545809A JP2025505142A5 JP 2025505142 A5 JP2025505142 A5 JP 2025505142A5 JP 2024545809 A JP2024545809 A JP 2024545809A JP 2024545809 A JP2024545809 A JP 2024545809A JP 2025505142 A5 JP2025505142 A5 JP 2025505142A5
Authority
JP
Japan
Prior art keywords
xrpd pattern
morphology according
cukα
crystal morphology
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024545809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505142A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/012252 external-priority patent/WO2023150250A1/en
Publication of JP2025505142A publication Critical patent/JP2025505142A/ja
Publication of JP2025505142A5 publication Critical patent/JP2025505142A5/ja
Pending legal-status Critical Current

Links

JP2024545809A 2022-02-04 2023-02-03 ムリザトクラクス(amg397)の結晶塩及び溶媒和物形態 Pending JP2025505142A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263306781P 2022-02-04 2022-02-04
US63/306,781 2022-02-04
PCT/US2023/012252 WO2023150250A1 (en) 2022-02-04 2023-02-03 Crystalline salt and solvate forms of murizatoclax (amg 397)

Publications (2)

Publication Number Publication Date
JP2025505142A JP2025505142A (ja) 2025-02-21
JP2025505142A5 true JP2025505142A5 (cg-RX-API-DMAC10.html) 2026-03-11

Family

ID=86054183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024545809A Pending JP2025505142A (ja) 2022-02-04 2023-02-03 ムリザトクラクス(amg397)の結晶塩及び溶媒和物形態

Country Status (7)

Country Link
US (1) US20250122224A1 (cg-RX-API-DMAC10.html)
EP (1) EP4472985A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025505142A (cg-RX-API-DMAC10.html)
AU (1) AU2023215171A1 (cg-RX-API-DMAC10.html)
CA (1) CA3248348A1 (cg-RX-API-DMAC10.html)
MX (1) MX2024009650A (cg-RX-API-DMAC10.html)
WO (1) WO2023150250A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119255998A (zh) 2022-05-04 2025-01-03 吉利德科学公司 特定mcl-1抑制剂的盐和多晶型物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8576985B2 (en) 2009-09-01 2013-11-05 Aptuit (West Lafayette) Llc Methods for indexing solid forms of compounds
JP6453507B2 (ja) * 2017-03-30 2019-01-16 アムジエン・インコーポレーテツド Mcl−1タンパク質を阻害する化合物
JP7873057B2 (ja) * 2020-03-31 2026-06-11 アムジエン・インコーポレーテツド Mcl-1化合物のメチル化

Similar Documents

Publication Publication Date Title
JP6810148B2 (ja) Dubの阻害剤としてのシアノピロリジン誘導体
ES2249884T3 (es) Derivados del acido indolil-3-glioxilico con efecto antitumoral.
HU223778B1 (hu) Új kinuklidinszármazékok és ezeket tartalmazó gyógyászati készítmények
CA2345146C (en) Cyanophenyl derivative
US8058444B2 (en) Heterocycle-substituted pyridine derivative's salt or crystal thereof
EP0931077B1 (en) Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
EP3492467A1 (en) Isoquinolinone compound and use thereof in preparation of antiviral drugs
JP2009535340A5 (cg-RX-API-DMAC10.html)
HK1252449A1 (zh) 突变的异柠檬酸脱氢酶idh1 r132h的抑制剂
US11028069B2 (en) Salt of substituted piperidine compound
WO2016016766A2 (en) A process for the preparation of isavuconazonium or its salt thereof
US20210130333A1 (en) Crystal of benzofuran derivative free base and preparation method
CN110590749A (zh) 吡啶胺基嘧啶衍生物甲磺酸盐的结晶形式及其制备和应用
HU198014B (en) Process for producing antiarithmic sulfonamides and pharmaceutical compositions containing them
KR102912761B1 (ko) [(1S)-1-[(2S,4R,5R)-5-(5-아미노-2-옥소-티아졸로[4,5-d]피리미딘-3-일)-4-하이드록시-테트라하이드로퓨란-2-일]프로필]아세테이트의 고체 형태
EP3100735B1 (en) Crystalline fosaprepitant dicyclohexylamine salt and its preparation
CN115702154A (zh) 一种嘧啶类化合物的盐和晶型及其制备方法
JP2025511331A5 (cg-RX-API-DMAC10.html)
JP2025513774A5 (cg-RX-API-DMAC10.html)
US8138349B2 (en) Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
JP2025505141A5 (cg-RX-API-DMAC10.html)
US5574054A (en) Quaternary ammonium salts and use thereof as medicine
JP7750535B2 (ja) 化合物の結晶形態
TW202440586A (zh) 口奈啶化合物的固體形式
CN119731185A (zh) 取代的1-芳基-1'-杂芳基化合物和取代的1,1'-双杂芳基化合物及其类似物的合成